{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:57:00Z","timestamp":1769126220497,"version":"3.49.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T00:00:00Z","timestamp":1647648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"crossref","award":["R322-2019-2698"],"award-info":[{"award-number":["R322-2019-2698"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondation Leducq Transatlantic Network of Excellence"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF14CC0001"],"award-info":[{"award-number":["NNF14CC0001"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004836","name":"Danish Council for independent Research","doi-asserted-by":"crossref","award":["DFF-4092-00045"],"award-info":[{"award-number":["DFF-4092-00045"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heart failure is a multifactorial disease that affects an estimated 38 million people worldwide. Current pharmacotherapy of heart failure with reduced ejection fraction (HFrEF) includes combination therapy with angiotensin-converting enzyme inhibitors (ACEi) and \u03b2-adrenergic receptor blockers (\u03b2-AR blockers), a therapy also used as treatment for non-cardiac conditions. Our knowledge of the molecular changes accompanying treatment with ACEi and \u03b2-AR blockers is limited. Here, we applied proteomics and phosphoproteomics approaches to profile the global changes in protein abundance and phosphorylation state in cardiac left ventricles consequent to combination therapy of \u03b2-AR blocker and ACE inhibitor in HFrEF and control hearts. The phosphorylation changes induced by treatment were profoundly different for failing than for non-failing hearts. HFrEF was characterized by profound downregulation of mitochondrial proteins coupled with derangement of \u03b2-adrenergic and pyruvate dehydrogenase signaling. Upon treatment, phosphorylation changes consequent to HFrEF were reversed. In control hearts, treatment mainly led to downregulation of canonical PKA signaling. The observation of divergent signaling outcomes depending on disease state underscores the importance of evaluating drug effects within the context of the specific conditions present in the recipient heart.<\/jats:p>","DOI":"10.1038\/s41598-022-08534-0","type":"journal-article","created":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T11:02:38Z","timestamp":1647687758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Beta-blocker\/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts"],"prefix":"10.1038","volume":"12","author":[{"given":"Andrea","family":"Sorrentino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navratan","family":"Bagwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Linscheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pi C.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Kahnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten B.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Delmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Lundby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,19]]},"reference":[{"key":"8534_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian, B. & Fonarow, G. C. Epidemiology and aetiology of heart failure. Nat. Rev. Cardiol. 13, 368\u2013378 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"8534_CR2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/dom.13652","volume":"21","author":"DSH Bell","year":"2019","unstructured":"Bell, D. S. H. & Goncalves, E. Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications. Diabetes Obes. Metab. 21, 1277\u20131290 (2019).","journal-title":"Diabetes Obes. Metab."},{"key":"8534_CR3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/heart.83.5.596","volume":"83","author":"JJ McMurray","year":"2000","unstructured":"McMurray, J. J. & Stewart, S. Epidemiology, aetiology, and prognosis of heart failure. Heart 83, 596\u2013602 (2000).","journal-title":"Heart"},{"key":"8534_CR4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer, M. A., Shah, A. M. & Borlaug, B. A. Heart failure with preserved ejection fraction in perspective. Circ Res. 124, 1598\u20131617 (2019).","journal-title":"Circ Res."},{"key":"8534_CR5","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah, K. S. et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J. Am. Coll. Cardiol. 70, 2476\u20132486 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"8534_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","volume":"115","author":"K Sharma","year":"2014","unstructured":"Sharma, K. & Kass, D. A. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ. Res. 115, 79\u201396 (2014).","journal-title":"Circ. Res."},{"key":"8534_CR7","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jacc.2019.03.478","volume":"73","author":"P van der Meer","year":"2019","unstructured":"van der Meer, P., Gaggin, H. K. & Dec, G. W. ACC\/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J. Am. Coll. Cardiol. 73, 2756\u20132768 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"8534_CR8","unstructured":"Writing Committee, M., Bozkurt, B., Coats, A. & Tsutsui, H. A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure Consensus Conference. Eur. J. Heart Fail. (2021)."},{"key":"8534_CR9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy, C. W. et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart failure society of America. J. Am. Coll. Cardiol. 70, 776\u2013803 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"8534_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/HCO.0b013e328333d3d6","volume":"25","author":"T Aiba","year":"2010","unstructured":"Aiba, T. & Tomaselli, G. F. Electrical remodeling in the failing heart. Curr. Opin. Cardiol. 25, 29\u201336 (2010).","journal-title":"Curr. Opin. Cardiol."},{"key":"8534_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero, E. & Maack, C. Metabolic remodelling in heart failure. Nat. Rev. Cardiol. 15, 457\u2013470 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"8534_CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tips.2010.12.001","volume":"32","author":"MJ Cutler","year":"2011","unstructured":"Cutler, M. J., Jeyaraj, D. & Rosenbaum, D. S. Cardiac electrical remodeling in health and disease. Trends Pharmacol. Sci. 32, 174\u2013180 (2011).","journal-title":"Trends Pharmacol. Sci."},{"key":"8534_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCGENETICS.110.957571","volume":"4","author":"AS Barth","year":"2011","unstructured":"Barth, A. S. et al. Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ. Cardiovasc. Genet. 4, 475\u2013483 (2011).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"8534_CR14","doi-asserted-by":"crossref","first-page":"e017091","DOI":"10.1161\/JAHA.120.017091","volume":"9","author":"T Caspi","year":"2020","unstructured":"Caspi, T. et al. Unique transcriptome signature distinguishes patients with heart failure with myopathy. J. Am. Heart Assoc. 9, e017091 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"8534_CR15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1074\/mcp.RA119.001878","volume":"19","author":"N Linscheid","year":"2020","unstructured":"Linscheid, N. et al. Quantitative proteomics of human heart samples collected in vivo reveal the remodeled protein landscape of dilated left atrium without atrial fibrillation. Mol. Cell Proteomics. 19, 1132\u20131144 (2020).","journal-title":"Mol. Cell Proteomics."},{"key":"8534_CR16","doi-asserted-by":"crossref","first-page":"e8503","DOI":"10.15252\/msb.20188503","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang, D. et al. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol. Syst. Biol. 15, e8503 (2019).","journal-title":"Mol. Syst. Biol."},{"key":"8534_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-017-02467-3","volume":"9","author":"E Lau","year":"2018","unstructured":"Lau, E. et al. Integrated omics dissection of proteome dynamics during cardiac remodeling. Nat. Commun. 9, 120 (2018).","journal-title":"Nat. Commun."},{"key":"8534_CR18","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1073\/pnas.1606444113","volume":"113","author":"U Kuzmanov","year":"2016","unstructured":"Kuzmanov, U. et al. Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy. Proc. Natl. Acad. Sci. U S A. 113, 12592\u201312597 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"8534_CR19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-020-0585-y","volume":"4","author":"U Kuzmanov","year":"2020","unstructured":"Kuzmanov, U. et al. Mapping signalling perturbations in myocardial fibrosis via the integrative phosphoproteomic profiling of tissue from diverse sources. Nat. Biomed. Eng. 4, 889\u2013900 (2020).","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"8534_CR20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","volume":"143","author":"JJV McMurray","year":"2020","unstructured":"McMurray, J. J. V. & Packer, M. How should we sequence the treatments for heart failure and a reduced ejection fraction? A redefinition of evidence-based medicine. Circulation 143(9), 875\u2013877 (2020).","journal-title":"Circulation"},{"key":"8534_CR21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 37, 2129\u20132200 (2016).","journal-title":"Eur. Heart J."},{"key":"8534_CR22","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","volume":"70","author":"GL Bakris","year":"2006","unstructured":"Bakris, G. L., Hart, P. & Ritz, E. Beta blockers in the management of chronic kidney disease. Kidney Int. 70, 1905\u20131913 (2006).","journal-title":"Kidney Int."},{"key":"8534_CR23","doi-asserted-by":"crossref","first-page":"e009992","DOI":"10.1161\/JAHA.118.009992","volume":"7","author":"E Ku","year":"2018","unstructured":"Ku, E., McCulloch, C. E., Vittinghoff, E., Lin, F. & Johansen, K. L. Use of antihypertensive agents and association with risk of adverse outcomes in chronic kidney disease: focus on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. J. Am. Heart Assoc. 7, e009992 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"8534_CR24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2006.05.029","volume":"51","author":"M Hamai","year":"2006","unstructured":"Hamai, M. et al. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress. Neuropharmacology 51, 822\u2013828 (2006).","journal-title":"Neuropharmacology"},{"key":"8534_CR25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/cvr\/cvp168","volume":"84","author":"DY Zhan","year":"2009","unstructured":"Zhan, D. Y. et al. Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation. Cardiovasc. Res. 84, 64\u201371 (2009).","journal-title":"Cardiovasc. Res."},{"key":"8534_CR26","doi-asserted-by":"crossref","first-page":"rs11","DOI":"10.1126\/scisignal.2003506","volume":"6","author":"A Lundby","year":"2013","unstructured":"Lundby, A. et al. In vivo phosphoproteomics analysis reveals the cardiac targets of \u03b2-adrenergic receptor signaling. Sci Signal. 6, rs11 (2013).","journal-title":"Sci Signal."},{"key":"8534_CR27","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1021\/pr500893m","volume":"13","author":"TS Batth","year":"2014","unstructured":"Batth, T. S., Francavilla, C. & Olsen, J. V. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J. Proteome Res. 13, 6176\u20136186 (2014).","journal-title":"J. Proteome Res."},{"key":"8534_CR28","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1038\/s41467-019-10709-9","volume":"10","author":"N Linscheid","year":"2019","unstructured":"Linscheid, N. et al. Quantitative proteomics and single-nucleus transcriptomics of the sinus node elucidates the foundation of cardiac pacemaking. Nat. Commun. 10, 2889 (2019).","journal-title":"Nat. Commun."},{"key":"8534_CR29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cell.2010.12.001","volume":"143","author":"EL Huttlin","year":"2010","unstructured":"Huttlin, E. L. et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174\u20131189 (2010).","journal-title":"Cell"},{"key":"8534_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2019.09.008","volume":"179","author":"A Lundby","year":"2019","unstructured":"Lundby, A. et al. Oncogenic mutations rewire signaling pathways by switching protein recruitment to phosphotyrosine sites. Cell 179, 543-560.e26 (2019).","journal-title":"Cell"},{"key":"8534_CR31","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cmet.2019.02.012","volume":"29","author":"F Sacco","year":"2019","unstructured":"Sacco, F. et al. Phosphoproteomics reveals the GSK3-PDX1 axis as a key pathogenic signaling node in diabetic islets. Cell Metab. 29, 1422-1432.e3 (2019).","journal-title":"Cell Metab."},{"key":"8534_CR32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.CIR.0000133440.86427.26","volume":"109","author":"GH Gibbons","year":"2004","unstructured":"Gibbons, G. H. et al. Genetic markers: progress and potential for cardiovascular disease. Circulation 109, 47\u201358 (2004).","journal-title":"Circulation"},{"key":"8534_CR33","doi-asserted-by":"crossref","first-page":"H1500","DOI":"10.1152\/ajpheart.2000.278.5.H1500","volume":"278","author":"T Langenickel","year":"2000","unstructured":"Langenickel, T., Pagel, I., H\u00f6hnel, K., Dietz, R. & Willenbrock, R. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am. J. Physiology-Heart Circ. Physiol. 278, H1500\u2013H1506 (2000).","journal-title":"Am. J. Physiology-Heart Circ. Physiol."},{"key":"8534_CR34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"8534_CR35","doi-asserted-by":"crossref","first-page":"M5","DOI":"10.1093\/eurheartj\/suz215","volume":"21","author":"I Spoletini","year":"2019","unstructured":"Spoletini, I., Coats, A. J. S., Senni, M. & Rosano, G. M. C. Monitoring of biomarkers in heart failure. Eur. Heart J. Suppl. 21, M5\u2013M8 (2019).","journal-title":"Eur. Heart J. Suppl."},{"key":"8534_CR36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.RES.71.1.9","volume":"71","author":"T Takahashi","year":"1992","unstructured":"Takahashi, T., Allen, P. D. & Izumo, S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene. Circ Res. 71, 9\u201317 (1992).","journal-title":"Circ Res."},{"key":"8534_CR37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","volume":"7","author":"BE Sansbury","year":"2014","unstructured":"Sansbury, B. E. et al. Metabolomic analysis of pressure-overloaded and infarcted mouse hearts. Circ. Heart Fail. 7, 634\u2013642 (2014).","journal-title":"Circ. Heart Fail."},{"key":"8534_CR38","doi-asserted-by":"crossref","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","volume":"8","author":"DH Tran","year":"2019","unstructured":"Tran, D. H. & Wang, Z. V. Glucose metabolism in cardiac hypertrophy and heart failure. J. Am. Heart Assoc. 8, e012673 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"8534_CR39","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/01.CIR.74.6.1290","volume":"74","author":"MB Fowler","year":"1986","unstructured":"Fowler, M. B., Laser, J. A., Hopkins, G. L., Minobe, W. & Bristow, M. R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74, 1290\u20131302 (1986).","journal-title":"Circulation"},{"key":"8534_CR40","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1093\/bioinformatics\/btx415","volume":"33","author":"DD Wiredja","year":"2017","unstructured":"Wiredja, D. D., Koyut\u00fcrk, M. & Chance, M. R. The KSEA App: a web-based tool for kinase activity inference from quantitative phosphoproteomics. Bioinformatics 33, 3489\u20133491 (2017).","journal-title":"Bioinformatics"},{"key":"8534_CR41","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/CIRCULATIONAHA.110.003665","volume":"123","author":"GH Eom","year":"2011","unstructured":"Eom, G. H. et al. Casein kinase-2\u03b11 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Circulation 123, 2392\u20132403 (2011).","journal-title":"Circulation"},{"key":"8534_CR42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/01.RES.0000038114.17939.C8","volume":"91","author":"K Kohlstedt","year":"2002","unstructured":"Kohlstedt, K., Shoghi, F., M\u00fcller-Esterl, W., Busse, R. & Fleming, I. CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circ. Res. 91, 749\u2013756 (2002).","journal-title":"Circ. Res."},{"key":"8534_CR43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan, D. H. & Kranias, E. G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4, 566\u2013577 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"8534_CR44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","volume":"70","author":"DM Bers","year":"2008","unstructured":"Bers, D. M. Calcium cycling and signaling in cardiac myocytes. Ann. Rev. Physiol. 70, 23\u201349 (2008).","journal-title":"Ann. Rev. Physiol."},{"key":"8534_CR45","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1021\/acs.jproteome.5b00107","volume":"14","author":"AW Herren","year":"2015","unstructured":"Herren, A. W. et al. CaMKII Phosphorylation of Na(V)1.5: novel in vitro sites identified by mass spectrometry and reduced s516 phosphorylation in human heart failure. J. Proteome Res. 14, 2298\u20132311 (2015).","journal-title":"J. Proteome Res."},{"key":"8534_CR46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.hrthm.2018.01.024","volume":"15","author":"T Shugg","year":"2018","unstructured":"Shugg, T. et al. Calcium\/calmodulin-dependent protein kinase II regulation of I(Ks) during sustained \u03b2-adrenergic receptor stimulation. Heart Rhythm 15, 895\u2013904 (2018).","journal-title":"Heart Rhythm"},{"key":"8534_CR47","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1074\/jbc.M115.638585","volume":"290","author":"F Ahmad","year":"2015","unstructured":"Ahmad, F. et al. Regulation of Sarcoplasmic Reticulum Ca2+ ATPase 2 (SERCA2) Activity by Phosphodiesterase 3A (PDE3A) in Human Myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2*. J. Biol. Chem. 290, 6763\u20136776 (2015).","journal-title":"J. Biol. Chem."},{"key":"8534_CR48","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.amjcard.2010.08.023","volume":"106","author":"CVS Ram","year":"2010","unstructured":"Ram, C. V. S. Beta-blockers in hypertension. Am. J. Cardiol. 106, 1819\u20131825 (2010).","journal-title":"Am. J. Cardiol."},{"key":"8534_CR49","doi-asserted-by":"crossref","first-page":"919256","DOI":"10.1155\/2014\/919256","volume":"2014","author":"H Tomiyama","year":"2014","unstructured":"Tomiyama, H. & Yamashina, A. Beta-blockers in the management of hypertension and\/or chronic kidney disease. Int. J. Hypertens. 2014, 919256 (2014).","journal-title":"Int. J. Hypertens."},{"key":"8534_CR50","doi-asserted-by":"crossref","first-page":"e0176450","DOI":"10.1371\/journal.pone.0176450","volume":"12","author":"L Hinz","year":"2017","unstructured":"Hinz, L., Ahles, A., Ruprecht, B., K\u00fcster, B. & Engelhardt, S. Two serines in the distal C-terminus of the human \u00df1-adrenoceptor determine \u00df-arrestin2 recruitment. PLoS ONE 12, e0176450 (2017).","journal-title":"PLoS ONE"},{"key":"8534_CR51","doi-asserted-by":"crossref","first-page":"17223","DOI":"10.1074\/jbc.272.27.17223","volume":"272","author":"HA Rockman","year":"1997","unstructured":"Rockman, H. A., Hunter, J. J., Choi, D.-J. & Koch, W. J. Mechanism of \u03b2-adrenergic receptor desensitization in cardiac hypertrophy is increased \u03b2-adrenergic receptor kinase*. J. Biol. Chem. 272, 17223\u201317229 (1997).","journal-title":"J. Biol. Chem."},{"key":"8534_CR52","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1113\/jphysiol.2013.263483","volume":"591","author":"T Speerschneider","year":"2013","unstructured":"Speerschneider, T. et al. Development of heart failure is independent of K+ channel-interacting protein 2 expression. J. Physiol. 591, 5923\u20135937 (2013).","journal-title":"J. Physiol."},{"key":"8534_CR53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/jmcc.2000.1308","volume":"33","author":"E Dupont","year":"2001","unstructured":"Dupont, E. et al. Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol. 33, 359\u2013371 (2001).","journal-title":"J Mol Cell Cardiol."},{"key":"8534_CR54","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.RES.86.12.1193","volume":"86","author":"HJ Jongsma","year":"2000","unstructured":"Jongsma, H. J. & Wilders, R. Gap junctions in cardiovascular disease. Circ Res. 86, 1193\u20131197 (2000).","journal-title":"Circ Res."},{"key":"8534_CR55","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.119.039710","volume":"140","author":"JC Kim","year":"2019","unstructured":"Kim, J. C. et al. Disruption of Ca(2+)i homeostasis and connexin 43 hemichannel function in the right ventricle precedes overt arrhythmogenic cardiomyopathy in plakophilin-2-deficient mice. Circulation 140, 1015\u20131030 (2019).","journal-title":"Circulation"},{"key":"8534_CR56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00424-014-1462-x","volume":"466","author":"K Lorenz","year":"2014","unstructured":"Lorenz, K., Stathopoulou, K., Schmid, E., Eder, P. & Cuello, F. Heart failure-specific changes in protein kinase signalling. Pfl\u00fcgers Arch. Eur. J. Physiol. 466, 1151\u20131162 (2014).","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"8534_CR57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fphar.2014.00005","volume":"5","author":"A Mattiazzi","year":"2014","unstructured":"Mattiazzi, A. & Kranias, E. G. The role of CaMKII regulation of phospholamban activity in heart disease. Front Pharmacol. 5, 5 (2014).","journal-title":"Front Pharmacol."},{"key":"8534_CR58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcvm.2018.00017","volume":"5","author":"K Gopal","year":"2018","unstructured":"Gopal, K. et al. Cardiac-specific deletion of pyruvate dehydrogenase impairs glucose oxidation rates and induces diastolic dysfunction. Front Cardiovasc Med. 5, 17 (2018).","journal-title":"Front Cardiovasc Med."},{"key":"8534_CR59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","volume":"118","author":"C Riehle","year":"2016","unstructured":"Riehle, C. & Abel, E. D. Insulin Signaling and Heart Failure. Circ. Res. 118, 1151\u20131169 (2016).","journal-title":"Circ. Res."},{"key":"8534_CR60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardiores.2004.12.022","volume":"66","author":"J Layland","year":"2005","unstructured":"Layland, J., Solaro, R. J. & Shah, A. M. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc. Res. 66, 12\u201321 (2005).","journal-title":"Cardiovasc. Res."},{"key":"8534_CR61","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.bpj.2014.07.027","volume":"107","author":"V Rao","year":"2014","unstructured":"Rao, V. et al. PKA phosphorylation of cardiac troponin I modulates activation and relaxation kinetics of ventricular myofibrils. Biophys. J. 107, 1196\u20131204 (2014).","journal-title":"Biophys. J."},{"key":"8534_CR62","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphar.2018.00904","volume":"9","author":"C de Lucia","year":"2018","unstructured":"de Lucia, C., Eguchi, A. & Koch, W. J. New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging. Front Pharmacol. 9, 904\u2013904 (2018).","journal-title":"Front Pharmacol."},{"key":"8534_CR63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2017.09.006","volume":"113","author":"B Steinhorn","year":"2017","unstructured":"Steinhorn, B. et al. Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4. Free Radic. Biol. Med. 113, 16\u201325 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"8534_CR64","doi-asserted-by":"crossref","first-page":"E577","DOI":"10.1152\/ajpendo.00014.2017","volume":"313","author":"T Li","year":"2017","unstructured":"Li, T. et al. Glucose oxidation positively regulates glucose uptake and improves cardiac function recovery after myocardial reperfusion. Am. J. Physiol. Endocrinol. Metab. 313, E577-e585 (2017).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"8534_CR65","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCRESAHA.117.311456","volume":"121","author":"LX Liu","year":"2017","unstructured":"Liu, L. X. et al. PDK4 inhibits cardiac pyruvate oxidation in late pregnancy. Circ. Res. 121, 1370\u20131378 (2017).","journal-title":"Circ. Res."},{"key":"8534_CR66","doi-asserted-by":"crossref","first-page":"H936","DOI":"10.1152\/ajpheart.00870.2007","volume":"294","author":"G Zhao","year":"2008","unstructured":"Zhao, G. et al. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am. J. Physio.l Heart Circ. Physiol. 294, H936\u2013H943 (2008).","journal-title":"Am. J. Physio.l Heart Circ. Physiol."},{"key":"8534_CR67","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res."},{"key":"8534_CR68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucl. Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucl. Acids Res."},{"key":"8534_CR69","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"8534_CR70","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: integrating viruses and cellular organisms. Nucl. Acids Res. 49, D545\u2013D551 (2021).","journal-title":"Nucl. Acids Res."},{"key":"8534_CR71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12859-016-1433-7","volume":"18","author":"S Eid","year":"2017","unstructured":"Eid, S., Turk, S., Volkamer, A., Rippmann, F. & Fulle, S. KinMap: a web-based tool for interactive navigation through human kinome data. BMC Bioinformatics 18, 16 (2017).","journal-title":"BMC Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08534-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:24:15Z","timestamp":1669335855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08534-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8534"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08534-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,19]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4760"}}